Epidemiology of French Sexual Offenders. A Cross-sectional Study
NCT Number: NCT06499051
Acronym: ARAVS
Status: RECRUITING
Study Type: OBSERVATIONAL
Conditions: Psychiatric Disorder
Interventions: OTHER: cognition, impulsivity, emotional regulation, sexuality, diagnosis, sexual violence, motivation, self-esteem, social desirability, and defense mechanisms
Sponsor: Hôpital le Vinatier
Sex: ALL
Age: ADULT, OLDER_ADULT
Enrollment: 400
Study Design: Observational Model: |Time Perspective: p
Start Date: 2024-05-10
Completion Date: 2027-09-01
Locations: CRIAVS - Centre Hospitalier Le Vinatier, Bron, 69678, France

Summary:
The epidemiology of sexual offenders has been poorly studied in the literature. A retrospective and prospective study will allow for the examination of the clinical profile of sexual offense perpetrators, risk and recurrence factors, as well as psychiatric or medical treatment. Since 2015, the Auvergne-Rhône-Alpes region has 8 reference platforms for sexual offense perpetrators, offering personalized assessment according to criteria defined by the Regional Health Agency (ARS). After this assessment, a multidisciplinary meeting is organized to define a tailored care plan. This study, called ARAVS (Auvergne Rhone-Alpes Sexual Offenders), aims to conduct an epidemiological, clinical, and socio-demographic study of patients in these platforms.

Primary Outcome Measures: Risk of re-offending and associated factors of the participant, Sexual offender recidivism risk will be assessed using Static99 scale. The Static-99 (Hanson \& Thornton, 2000) is the most commonly used actuarial risk tool for estimating sexual offender recidivism risk.The risk assessment instrument Static-99R consists of ten items, where all but items 1 and 5 are dichotomous, resulting in 0 or 1 point being added to the total score. The total score, between -3 and 12, results in one out of five recommended risk levels: level I - very low risk (scores of -3 to -2), level II - below average risk (scores of -1 to 0), level III - average risk (scores of 1 to 3), level IVa - above average risk (scores of 4 to 5), and level IVb - well above average risk (scores of 6+)., From May 2024 to May 2027
Secondary Outcome Measures: Impulsivity of the participant, Impulsivity will be assessed using the UPPS-P ( Impulsive Behavior Scale) scale. Participants are asked to consider acts/incidents during the last 6 months when rating their behavior and attitudes on a 4-point scale, in which 1-Agree strongly, 2-Agree some, 3-Disagree some, 4-Disagree strongly. This is a 59-item scale measuring 5 impulsivity components: negative urgency, positive urgency, lack of premeditation, lack of perseverance, and sensation seeking.Scores are presented for each of five subscales, plus a total impulsivity score.In addition to the raw scores, the mean is calculated for the items on each subscale, from 1 to 4, where 1 indicates that the respondent did not endorse impulsive answers, and 4 indicates a high level of self-reported impulsivity., From May 2024 to May 2027 (cross-sectional study)|Cognition of the participant, Cognition will be assessed using The Patient Competency Rating Scale (PCRS). The PCRS consists of 30 items, each scored on a scale of 1 to 5, making the total score range from 30 to 150. The higher scores indicate greater competency in the list of skills on the test., From May 2024 to May 2027 (cross-sectional study)|Emotional status of the participant, Emotional status will be assessed using theTAS-20 (Toronto Alexithymia Scale) scale. The TAS-20 is a self-report scale that is comprised of 20 items. Items are rated using a 5-point Likert scale whereby 1 = strongly disagree and 5 = strongly agree. There are 5 items that are negatively keyed (items 4, 5, 10, 18 and 19). The total alexithymia score is the sum of responses to all 20 items.The TAS-20 uses cutoff scoring: equal to or less than 51 = non-alexithymia, equal to or greater than 61 = alexithymia. Scores of 52 to 60 = possible alexithymia., From May 2024 to May 2027 (cross-sectional study)|Diagnosis of the participant, Diagnosis will be assessed using the PCL-R scale (Psychopathy Checklist Revised). The scale includes 2 factors. Factor 1 is a measure of Emotional Detachment (e.g., superficial charm, manipulativeness, shallow affectivity, absence of guilt or empathy). Factor 2 is a measure of Antisocial Behavior (deviance from an early age, aggression, impulsivity, irresponsibility, proneness to boredom). There is also a total score. A total score of 10-19 diagnoses an individual as midly psychopathic. A score of 20-29 diagnoses them as moderately psychopathic. a score of 30-40 diagnoses them as severely psychopathic., From May 2024 to May 2027 (cross-sectional study)|Cognitive distorsions of the participant, Cognitive distorsions will be assessed using the bumby RAPE (BRS) and MOLEST (BMS) scales. The MOLEST scale is composed of 38 items and the RAPE scale is composed of 36 items scored on a 4-point Likert scale from strongly agree to strongly disagree. The BMS consists of38 items with a range of total scores being a minimum of 38 and a maximum of 152, and the BRS consists of 36 items with a total score ranging from 36 to 144., From May 2024 to May 2027 ((cross-sectional study)|Pedophilic Interests of the participant, pedophilic interests will be assessed using the Revised Screening Scale for Pedophilic Interests (SSPI-2). The SSPI-2 score ranges from zero to five, with higher scores indicating sexual interest in children., From May 2024 to May 2027 ((cross-sectional study)|Motivation of the participant, Motivation will be assessed using the URICA (University of Rhode Island Change Assessment Scale) scale. This is is a 32 item self-report measure that includes 4 subscales measuring the stages of change: Precontemplation, Contemplation, Action, and Maintenance. Responses are given on a 5 point Likert scale ranging from (1=strong disagreement to 5=strong agreement), An overall readiness to change score is calculated using a weighted average of the four sub-scores, where 14 is the maximum possible score. A higher score corresponds to increased readiness to change, From May 2024 to May 2027 ((cross-sectional study)|Self-esteem of the participant, Self-esteem will be assessed using the Rosenberg scale. The scale ranges from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem., From May 2024 to May 2027 (cross-sectional study)